Dave Palmieri

Chief Marketing Officer, Co-Founder


David Palmieri is a New York City Healthcare Consultant. A native New Yorker, David studied at Wagner College and Polytech University of New York and earned a Bachelor of Science Degree from The State University of New York. He earned a Doctorate of Chiropractic degree from New York Chiropractic College and developed a multi-discipline approach to spinal pain working with a number of well-respected rehabilitation, neurological and orthopedic physicians in the New York region.

Since 1988, David has developed and managed multidisciplinary medical teams to implement emerging medical technologies that meet the unique needs of suffering patients in New York State. While managing his own successful practice for 18 years, he became interested in non-narcotic, non-invasive treatments for chronic pain. Through personal research and close consultation with his medical team, his practice provided individualized health care to patients.

In 2005, Dr. Palmieri retired from clinical practice and founded his medical consulting firm, where he continues to seek out emerging technologies and clinical interventions that are scientifically based, and assists clinical practices with deployment and implementation. In practice and his personal life, his research for better medicine continued to lead him to the potential of cannabis based therapies. He became a voracious consumer of information related to cannabis’ therapeutic qualities and the fight for access and legalization for patients. When New York passed legislation approving medical cannabis products, David saw the opportunity it provided to help the people he’s treated his entire life and quickly assembled a medical and science team. Together with the right business partners, Citiva became a reality.

As Chief Marketing Officer, David brings a wealth of experience in healthcare marketing and emerging technologies. Energized by his enthusiasm for and belief in cannabinoid medicine, David is leading CITIVA to the forefront of the medical cannabis industry.

Shaping the Future of Cannabinoid Medicine
In the


View Our


Meet the